Cargando…
A Two-Stage Process for Differentiation of Wharton's Jelly-Derived Mesenchymal Stem Cells into Neuronal-like Cells
With no permanent cure for neurodegenerative diseases, the symptoms reappear shortly after the withdrawal of medicines. A better treatment outcome can be expected if the damaged neurons are partly replaced by functional neurons and/or they are repaired using trophic factors. In this regard, safe cel...
Autores principales: | Equbal, Zaffar, Baligar, Prakash N., Srivastava, Madhulika, Mukhopadhyay, Asok |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8177978/ https://www.ncbi.nlm.nih.gov/pubmed/34135973 http://dx.doi.org/10.1155/2021/6631651 |
Ejemplares similares
-
JMJD3 aids in reprogramming of bone marrow progenitor cells to hepatic phenotype through epigenetic activation of hepatic transcription factors
por: Kochat, Veena, et al.
Publicado: (2017) -
Differentiation of Wharton's jelly mesenchymal stem cells into neurons in alginate scaffold
por: Hosseini, Seyed Mojtaba, et al.
Publicado: (2015) -
The Immunomodulatory Potential of Wharton's Jelly Mesenchymal Stem/Stromal Cells
por: Vieira Paladino, Fernanda, et al.
Publicado: (2019) -
AFM-based Analysis of Wharton’s Jelly Mesenchymal Stem Cells
por: Szydlak, Renata, et al.
Publicado: (2019) -
Wharton's jelly mesenchymal stem cells differentiate into retinal progenitor cells
por: Hu, Ying, et al.
Publicado: (2013)